Our Products

Psoriasis and Vitiligo


Topical treatment for psoriasis and vitiligo.

Photocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation.

Sales Channels
Photocil became commercially available in the United States in Q4 2022 as an FDA-approved OTC product under a USP monograph for psoriasis and vitiligo.

Next Steps
The scientific formulation is finished, and clinical research is currently in progress.

Investor Alerts

Get our news

For up-to-date company news delivered straight to your inbox or phone, sign up for Investor Alerts today.

To receive alerts via text message, send JUPW to
 +1 (844) 819-8138